Literature DB >> 26231862

Solid lipid nanoparticles for delivery of Calendula officinalis extract.

Lide Arana1, Clarisa Salado2, Sandra Vega3, Oier Aizpurua-Olaizola4, Igor de la Arada1, Tatiana Suarez3, Aresatz Usobiaga4, José Luis R Arrondo1, Alicia Alonso1, Félix M Goñi1, Itziar Alkorta5.   

Abstract

Solid lipid nanoparticles (SLN) composed of long-chain fatty acids (palmitic acid, stearic acid or arachidic acid), Epikuron 200 (purified phosphatidylcholine), and bile salts (cholate, taurocholate or taurodeoxycholate) have been prepared by dilution of a microemulsion. A total of five different systems were prepared, and characterized by photon correlation spectroscopy, transmission electron microscopy, differential scanning calorimetry, and infrared spectroscopy. The SLN formulation showing optimal properties (lowest size and polydispersity index and highest zeta potential) was obtained with stearic acid and taurodeoxycholate as cosurfactant. This formulation was loaded with Calendula officinalis extract, a natural compound used on ophthalmic formulations given its anti-inflammatory, emollient, and wound repairing activity. Calendula-loaded SLN preparations were characterized in order to determine loading capacity and entrapment efficiency. In vitro cytotoxicity and wound healing efficacy of Calendula-loaded SLN compared to that of a free plant extract were evaluated on a conjunctival epithelium cell line WKD. Our results suggest that this SLN formulation is a safe and solvent-free Calendula extract delivery system which could provide a controlled therapeutic alternative for reducing disease-related symptoms and improving epithelium repair in ocular surface.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calendula officinalis; Cytotoxicity; Differential scanning calorimetry; Infrared spectroscopy; Re-epithelialization; Solid lipid nanoparticles

Mesh:

Substances:

Year:  2015        PMID: 26231862     DOI: 10.1016/j.colsurfb.2015.07.020

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  7 in total

1.  Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Authors:  Raju V S Rajala
Journal:  J Mol Biol Ther       Date:  2019

2.  Comparative Evaluation of the Effectiveness of a Combination of Absorbable Gelatin Sponge and Calendula officinalis with Absorbable Gelatin Sponge Used Alone as a Hemostatic Agent-An In-Vitro Study.

Authors:  Bharath Kumar Ayyanahalli Matta; Santhosh Kumar; Chetan Hasmukh Mehta; Usha Yogendra Nayak; Patricia Garcia Rodriguez
Journal:  Dent J (Basel)       Date:  2022-05-05

3.  Investigation of Cellular Interactions of Lipid-Structured Nanoparticles With Oral Mucosal Epithelial Cells.

Authors:  R Jeitler; C Glader; C Tetyczka; S Zeiringer; M Absenger-Novak; A Selmani; E Fröhlich; E Roblegg
Journal:  Front Mol Biosci       Date:  2022-05-23

Review 4.  Nanoencapsulation of carotenoids: a focus on different delivery systems and evaluation parameters.

Authors:  Priscilla Pereira Dos Santos; Larissa de Aguiar Andrade; Simone Hickmann Flôres; Alessandro de Oliveira Rios
Journal:  J Food Sci Technol       Date:  2018-07-05       Impact factor: 2.701

Review 5.  Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems.

Authors:  Marziyeh Hajialyani; Devesh Tewari; Eduardo Sobarzo-Sánchez; Seyed Mohammad Nabavi; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2018-09-03

Review 6.  The Use of Nanoparticles in Otoprotection.

Authors:  Maurizio Barbara; Valerio Margani; Edoardo Covelli; Chiara Filippi; Luigi Volpini; Ola M El-Borady; Maged El-Kemary; Saad Elzayat; Haitham H Elfarargy
Journal:  Front Neurol       Date:  2022-06-29       Impact factor: 4.086

7.  Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity.

Authors:  Blanca Cervantes; Lide Arana; Silvia Murillo-Cuesta; Marina Bruno; Itziar Alkorta; Isabel Varela-Nieto
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.